A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
A phase 1/2 trial of AZD0486, Prednisone, Rituximab in chronic lymphocytic leukaemia and mantle cell lymphoma, run by AstraZeneca, now recruiting.
Overview
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies is a phase 1/2 interventional study registered as NCT06564038 by AstraZeneca, with 408 participants planned, started 2025-01-30 and due to reach its primary completion in 2029-06-11. Interventions recorded: Surovatamig, Prednisone (or equivalent), Rituximab, Cyclophosphamide, Vincristine. Conditions listed: Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Th
Shares Prednisone, Vincristine, Rituximab, Cyclophosphamide.
- TrialA Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)
Shares Prednisone, Vincristine, Rituximab, Cyclophosphamide.
- TrialA Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
Shares Prednisone, Vincristine, Rituximab, Cyclophosphamide.
- TrialTucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
Shares Prednisone, Vincristine, Cyclophosphamide, Doxorubicin.
- TrialSafety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
Shares Prednisone, Vincristine, Rituximab, Cyclophosphamide.
- TrialClinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma
Shares Prednisone, Vincristine, Cyclophosphamide, Doxorubicin.
- TrialSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Shares AZD0486, Non-Hodgkin lymphoma (all types), Hodgkin lymphoma, AstraZeneca.
- TrialA Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituxi
Shares Prednisone, Vincristine, Rituximab, Cyclophosphamide.